Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

NOCANO: Nivolumab as neoadjuvant immunotherapy for patients with Oral CANcer and identification of response-predictive biomarkers in tumour … Pending

2025-521006-18-00 Oral squamous cell carcinoma (OSCC) 4
A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, a… Pending

2025-523590-42-00 Locally Advanced or Metastatic Solid Tumors 7
A study testing a new treatment called TK-6302 for the first time in people with advanced cancers that have a genetic marker called HLA-A02:… Pending

2025-521603-46-00 Advanced PRAME Positive Solid Tumors 1
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( R… Pending

2024-519818-31-01 Endometrial Cancer Advanced, Recurrent, Metastatic, or 5
A Study to Learn about the Long-Term Health of Adult Participants from a Previous Study of a New Melanoma Treatment Pending

2024-517729-20-00 Melanoma 4
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer Pending

2025-522204-24-00 Drug-Related Side Effects and Adverse Reactions 4
Study to assess how safe and effective is HRX215 in participants who underwent minor and major liver surgery due to colon carcinoma metastas… Pending

2025-523630-59-00 colon carcinoma metastases 9
Study evaluating two treatment strategies for rectal cancer in patients ≥75 years old Pending

2025-521619-37-00 Patients ≥75 years old with cT3/T4 rectal adenocarcinom 5
Impact of EXercise on quality of life of early breast cancer patients on treatment with adjuvant Aromatase Inhibitors with or without CDK4/6… Pending

2025-522848-40-00 Early Breast Cancer 6
Phase 1/2 Study of BLU-451 in certain advanced cancers Pending

2022-502527-21-00 Advanced cancers with EGFR Exon20 insertions mutations 7
EPITOME-1015-I: A phase I study to investigate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesop… Pending

2024-516787-28-00 Epithelial Ovarian Carcinoma 1
A phase I study of [68Ga]Ga-DWJ155 in patients with advanced breast and NSCLC cancers Pending

2024-517746-34-00 Advanced breast cancer and advanced NSCLC 1
A Study of Vepugratinib (LY3866288) in Participants with Cancer in the Urinary Tract ( FORAGER-2 ) Pending

2025-522855-25-00 Carcinoma, Transitional Cell 5
PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR… Pending

2025-524613-89-00 HER2 positive advanced breast cancer 9
Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer a… Pending

2024-517269-18-00 stage III colon adenocarcinoma with deficient MMR 5
The ALPINE trial: a phase 1-2 study of intra-arterial [177Lu]Lu-PSMA-I&T for progressive or recurrent intracranial adult type diffuse gliom… Pending

2023-504696-24-00 Glioma (diffuse astrocytoma, oligodendroglioma or gliob 7
FG001 in subjects with Meningiomas or presumed Low-Grade Gliomas scheduled for neurosurgery. Pending

2024-520426-11-00 Glioma 4
Trial to study the safety and pharmacokinetics of ODM-212 combined with existing cancer treatments Pending

2025-524620-22-00 Neoplasms benign malignant and unspecified (incl. cysts 9
ALASCCA-A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signa… Pending

2024-513778-23-00 Colon and rectal cancer tumor stage II-III, tumor with 5
Personalizing chemotherapy selection after surgery for patients with stage III colorectal cancer using a blood test Pending

2025-521045-24-00 Stage III colorectal cancer 5
Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases in patients with a low clinical risk sco… Pending

2024-512850-10-00 Resectable colorectal rectal metastases without extrahe 5
A Phase I study to evaluate the safety and efficacy of L19IL2 in combination with ruxolitinib in patients with advanced solid tumors. Pending

2025-522243-17-00 Advanced solid tumors, specifically: • metastatic clea 3
A study to evaluate the efficacy of oxaliplatin- or gemcitabine-based chemotherapy after allocation by standard criteria or by genetic marke… Pending

2024-514682-19-00 Resected pancreatic ductal adenocarcinoma 5
Skipping Hormone Therapy in Low-Risk Early Breast Cancer Pending

2025-523683-20-00 Postmenopausal patients with small (pT1a-b pN0) hormone 4